Data from CoinGecko, on-chain analytics, and official project documentation. View methodology
Cryptocurrency
Marinade Staked SOL (MSOL)
Sector
Liquid Staking
Market Cap Rank
#0
Current Price
$124.87
Market Capitalization
$258.46M
STRICT Score
72/100
Cycle Potential
6.8x
vs. bull target
Probability
62%
Success chance
Risk Level
7/10
High Risk
Market Cap
$258.46M
Volume
$688.43K
STRICT Score Breakdown
70
S
Sustainability
85
T
Transparency
62
R
Revenue
78
I
Innovation
58
C
Community
78
T
Tokenomics
Analysis Overview
Analysis Overview
mSOL is Marinade Finance's liquid staking token representing staked SOL on Solana, launched in March 2021 as Solana's first native liquid staking solution. Users stake SOL and receive mSOL, which automatically accrues staking rewards while remaining liquid for DeFi use across 100+ validators with algorithmic rebalancing. As of February 2026, mSOL has dropped to 5th place among liquid staking tokens as JitoSOL, dzSOL, and bnSOL significantly expanded their market share, marking a strategic recalibration for Marinade away from retail mSOL growth toward institutional staking products. The mSOL token trades at $114.62 (February 10, 2026) with -17.50% decline over 7 days, underperforming the broader crypto market (-10.30%). Marinade has pivoted toward institutional infrastructure: Marinade Select's SOL-denominated TVL increased 87.13% from 863k SOL in July 2025 to over 1.6M SOL in January 2026, surpassing 3.1M SOL by November 2025 with threefold monthly growth. The platform serves as exclusive staking partner for Canary Capital's Solana ETF (SOLC, first ETF passing through 100% staking rewards) and VisionSys AI's planned $2B SOL treasury. Marinade Native reached 4.9M SOL offering 10-11.8% APY. In December 2025, Marinade DAO passed MIP-17 to pause MNDE buybacks and redirect funds toward growing mSOL liquidity, resulting in mSOL supply increasing by approximately 22.3k tokens. As of January 29, 2026, validators can now set custom commission rates for Marinade stake, offering more flexibility in competing for delegation. Total Marinade TVL across all products stands at $1.2B (9.3M SOL in Q1 2025), with revenue reaching $3.6M in Q1 2025 (+328.4% YoY, +18.2% QoQ). JitoSOL maintains regulatory validation with 21Shares ETP (JSOL) on Euronext providing institutional access to MEV-enhanced yields.
Investment Thesis
Strengths
10
1Institutional infrastructure excellence: exclusive staking partner for Canary Solana ETF (SOLC, first ETF passing through 100% staking rewards)
2VisionSys AI partnership for planned $2B SOL treasury ($500M in first six months), Marinade as exclusive staking partner
3SOC 2 Type I & Type II compliance with BitGo, Zodia, and Copper custody integrations for institutional-grade security
4Marinade Select explosive growth: TVL increased 87.13% from 863k SOL (July 2025) to 1.6M SOL (January 2026), surpassing 3.1M SOL by November 2025
Upcoming Catalysts
5
Canary Solana ETF (SOLC) institutional adoption with Marinade Select as exclusive staking backend
Ongoing Q1 2026
Medium Impact
Analysis Overview
mSOL is Marinade Finance's liquid staking token representing staked SOL on Solana, launched in March 2021 as Solana's first native liquid staking solution. Users stake SOL and receive mSOL, which automatically accrues staking rewards while remaining liquid for DeFi use across 100+ validators with al…
Strengths
10
1Institutional infrastructure excellence: exclusive staking partner for Canary Solana ETF (SOLC, first ETF passing through 100% staking rewards)
2VisionSys AI partnership for planned $2B SOL treasury ($500M in first six months), Marinade as exclusive staking partner
3SOC 2 Type I & Type II compliance with BitGo, Zodia, and Copper custody integrations for institutional-grade security
4Marinade Select explosive growth: TVL increased 87.13% from 863k SOL (July 2025) to 1.6M SOL (January 2026), surpassing 3.1M SOL by November 2025
mSOL represents a mature liquid staking option for Solana holders prioritizing institutional-grade infrastructure and proven reliability, though its competitive positioning has deteriorated significantly as the protocol pivots away from retail LST market share toward institutional staking products. As of February 2026, mSOL has dropped to 5th place among liquid staking tokens, down from 2nd position in January 2026, as JitoSOL, dzSOL, bnSOL, and other competitors aggressively expanded. The token trades at $114.62 (February 10, 2026) with -17.50% decline over 7 days, underperforming the broader crypto market's -10.30% drop. Marinade's institutional credibility remains exceptional: exclusive staking partner for Canary Capital's Solana ETF (SOLC, first ETF passing through 100% staking rewards), VisionSys AI's planned $2B SOL treasury ($500M in first six months), and SOC 2 Type I & Type II compliance with BitGo, Zodia, and Copper custody integrations. Marinade Select's SOL-denominated TVL increased 87.13% from 863k SOL (July 2025) to over 1.6M SOL (January 2026), surpassing 3.1M SOL by November 2025 with threefold monthly growth. Native staking reached 4.9M SOL offering competitive 10-11.8% APY. Total Marinade protocol generated $3.6M revenue in Q1 2025 (+328.4% YoY, +18.2% QoQ) with $1.2B TVL (9.3M SOL) across all products. However, the strategic shift is unmistakable: in December 2025, Marinade DAO passed MIP-17 to pause MNDE buybacks and redirect funds toward growing mSOL liquidity rather than token value, with mSOL supply increasing 22.3k tokens since. This signals prioritization of institutional staking infrastructure (Select, Native) over competitive retail mSOL market share defense. JitoSOL maintains regulatory validation via 21Shares ETP (JSOL) on Euronext, catalyzing institutional flows toward MEV-enhanced yields that mSOL cannot match. Best suited for existing holders valuing proven infrastructure, 100+ validator decentralization, and institutional compliance, but new capital seeking liquid staking exposure should evaluate JitoSOL (regulatory validation, MEV rewards) or emerging competitors offering superior growth trajectories.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions. Cryptocurrency investments are volatile and carry significant risk.
mSOL represents a mature liquid staking option for Solana holders prioritizing institutional-grade infrastructure and proven reliability, though its competitive positioning has deteriorated significantly as the protocol pivots away from retail LST market share toward institutional staking products. As of February 2026, mSOL has dropped to 5th place among liquid staking tokens, down from 2nd position in January 2026, as JitoSOL, dzSOL, bnSOL, and other competitors aggressively expanded. The token trades at $114.62 (February 10, 2026) with -17.50% decline over 7 days, underperforming the broader crypto market's -10.30% drop. Marinade's institutional credibility remains exceptional: exclusive staking partner for Canary Capital's Solana ETF (SOLC, first ETF passing through 100% staking rewards), VisionSys AI's planned $2B SOL treasury ($500M in first six months), and SOC 2 Type I & Type II compliance with BitGo, Zodia, and Copper custody integrations. Marinade Select's SOL-denominated TVL increased 87.13% from 863k SOL (July 2025) to over 1.6M SOL (January 2026), surpassing 3.1M SOL by November 2025 with threefold monthly growth. Native staking reached 4.9M SOL offering competitive 10-11.8% APY. Total Marinade protocol generated $3.6M revenue in Q1 2025 (+328.4% YoY, +18.2% QoQ) with $1.2B TVL (9.3M SOL) across all products. However, the strategic shift is unmistakable: in December 2025, Marinade DAO passed MIP-17 to pause MNDE buybacks and redirect funds toward growing mSOL liquidity rather than token value, with mSOL supply increasing 22.3k tokens since. This signals prioritization of institutional staking infrastructure (Select, Native) over competitive retail mSOL market share defense. JitoSOL maintains regulatory validation via 21Shares ETP (JSOL) on Euronext, catalyzing institutional flows toward MEV-enhanced yields that mSOL cannot match. Best suited for existing holders valuing proven infrastructure, 100+ validator decentralization, and institutional compliance, but new capital seeking liquid staking exposure should evaluate JitoSOL (regulatory validation, MEV rewards) or emerging competitors offering superior growth trajectories.
Competitive Position
mSOL has dropped to 5th place among liquid staking tokens as of February 2026, down from 2nd position in January, marking a significant competitive setback as Marinade strategically pivots away from retail LST market share toward institutional staking infrastructure. The LST landscape continues fragmenting: JitoSOL, dzSOL, bnSOL, and other competitors aggressively expanded while mSOL market position deteriorated. JitoSOL maintains regulatory validation via 21Shares ETP (JSOL) on Euronext (January 29, 2026) with 0.99% expense ratio and MEV-enhanced yields, catalyzing institutional flows toward competitors. The total Solana LST market reached 60.5M SOL (13.76% of all staked Solana) by November 2025, with Sanctum-powered ecosystem enabling easy LST launches and shared liquidity fragmenting market share further. Marinade's competitive advantages now center on institutional infrastructure rather than retail LST dominance: exclusive staking partner for Canary Solana ETF (SOLC, first ETF passing through 100% staking rewards), VisionSys AI $2B SOL treasury partnership ($500M first six months), SOC 2 Type I & Type II compliance with BitGo/Zodia/Copper custody, and validator decentralization (100+ validators with algorithmic rebalancing). Marinade Select TVL increased 87.13% from 863k SOL (July 2025) to 1.6M SOL (January 2026), surpassing 3.1M SOL by November 2025 with threefold monthly growth. Native staking reached 4.9M SOL offering competitive 10-11.8% APY. Total Marinade protocol generated $3.6M revenue Q1 2025 (+328.4% YoY, +18.2% QoQ) with $1.2B TVL (9.3M SOL) across all products. However, the strategic shift is unmistakable: MIP-17 (December 2025) paused MNDE buybacks to redirect funds toward mSOL liquidity growth rather than token value, with mSOL supply increasing 22.3k tokens. Validator custom commission rates enabled January 29, 2026 for competitive delegation. Marinade has repositioned as institutional staking infrastructure provider (Select, Native) rather than yield-maximizing retail LST competitor, accepting market share loss in retail liquid staking market.
Conclusion
mSOL has transitioned from a competitive retail liquid staking token to a legacy infrastructure product as Marinade strategically pivots toward institutional staking solutions. As of February 2026, mSOL dropped to 5th place among LSTs (down from 2nd in January), with the token trading at $114.62 and declining -17.50% over 7 days (underperforming the broader market's -10.30%). Marinade's institutional infrastructure credentials remain exceptional: exclusive staking partner for Canary Solana ETF (SOLC, first ETF passing through 100% staking rewards), VisionSys AI $2B SOL treasury partnership ($500M first six months), SOC 2 Type I & Type II compliance with BitGo/Zodia/Copper custody, and 100+ validator decentralization with algorithmic rebalancing. Marinade Select TVL surged 87.13% from 863k SOL (July 2025) to 1.6M SOL (January 2026), reaching 3.1M+ SOL by November with threefold monthly growth. Native staking hit 4.9M SOL offering competitive 10-11.8% APY. Total Marinade protocol generated $3.6M revenue Q1 2025 (+328.4% YoY) with $1.2B TVL (9.3M SOL) across all products. However, the strategic shift is unmistakable: MIP-17 (December 2025) paused MNDE buybacks to redirect funds toward mSOL liquidity rather than token value, with mSOL supply increasing 22.3k tokens. JitoSOL maintains regulatory validation via 21Shares ETP (JSOL) on Euronext, catalyzing institutional flows toward MEV-enabled competitors. Current holders should HOLD if prioritizing proven infrastructure, institutional-grade security, and decentralization, as mSOL remains functional and liquid despite competitive deterioration. However, new capital seeking liquid staking exposure should evaluate JitoSOL (regulatory validation, MEV rewards), emerging LST competitors with superior growth trajectories, or Marinade's own Native staking (10-11.8% APY) for better risk-adjusted returns. mSOL best suits existing holders unwilling to switch protocols, valuing institutional compliance and proven reliability over competitive yield optimization and market share growth.
5
Native staking product at 4.9M SOL offering competitive 10-11.8% APY for users prioritizing yield over liquidity
6Record revenue trajectory: $3.6M Q1 2025 (+328.4% YoY, +18.2% QoQ), total Marinade TVL $1.2B (9.3M SOL) across all products
7Decentralized validator set (100+ validators with algorithmic rebalancing strengthening network security)
8Validator flexibility: custom commission rates enabled January 29, 2026, allowing more competitive delegation
